Find-Speaker.com




3rd Gamma Delta T Therapies Summit 2022 (description)

""

Category:Medicine
Address:120 Huntington Avenue Boston, Massachusetts, United States of America 02116
Phone:+1 617 455 4188
Event dates:7/26/2022 - 7/28/2022 (This event has already taken place)
Event web site:http://go.evvnt.com/1089722-3?pid=5188
findCE GPA: This event is not yet rated. Click here to view a sample report card
Click here to rate 3rd Gamma Delta T Therapies Summit 2022

Speakers/Presenters:

Topics to be Covered:

  • Blake Aftab, CSO, Adicet Bio
  • Francesco Galimi, CMO, Adicet Bio
  • Sai-Wen Tang, Director, R and D Acepodia
  • Frank Borriello, Scientific Founder and CEO, Alloplex Biotherapeutics
  • Science, Health and Medicine
  • Pharmaceuticals
  • Clinical
Contact:info@hansonwade.com
Organizer phone:+1 617 455 4188
Offering type:Conference
Specialty:Data not provided
Event frequency:Never
First Meeting:
Total events:
Est. attendance:
Target audience:Any
Other target audiences:
Host Sponsor:Hanson Wade
Est. # of exhibitors:
Currency:US Dollars
Language:Data not provided
CE Credits:
Organizer URL

Description:

With Adicet Bio, In8Bio, Gamma Delta Therapeutics, Lava Therapeutics, and ImCheck Therapeutics releasing clinical data from engineered and antibody-based γδT Therapy in patients; the race to market for the first allogeneic and solid tumor-targeting γδT Therapy is truly on.

Join the 3rd Gamma Delta T Therapies Summit to learn and network with 120+ of the world's leaders including γδT pioneer, Adrian Hayday, and together accelerate the development of effective, persistent, globally accessible cell therapy for solid tumors.

Enhance cytotoxicity, discover novel targets, engineer stealth and persistence, interrogate cell subsets, and scale-up manufacturing through a deep understanding of the fundamental biology and target product profile for γδT therapies.

Industry experts agree that this year, the γδT is the cell to know. Ensure you and your team are ahead of the curve and equipped with the need-to-know insights to advance successful therapeutics, across 2 dedicated tracks covering Discovery, Process Research, Preclinical, and Clinical Development; as well as 3 deep-dive workshops, and a Gamma Delta 101 Bootcamp.

Speakers: Jim Lederer, Associate Professor, Brigham and Women's Hospital, Mark Wallet, VP Head of Immunology, Century Therapeutics, Cheng Liu, President and CEO, Eureka Therapeutics, Stefania Gobessi, Director of Discovery, Gadeta, Oliver Nussbaumer, VP Immunology, GammaDelta Therapeutics, Victoria Coutinho, VP Regulatory Affairs, GammaDelta Therapeutics, Jonathan Fisher, Wellcome Trust Clinical Research Fellow, Great Ormand Street Hospital, UCL, Marta Barisa, Senior Research Fellow and Scientific Project Manager, Great Ormond Street Hospital, UCL, Paul Frohna, CMO, ImCheck Therapeutics, Annelise Vuidepot, CTO and Head of Platform and Pipeline Development, Immunocore, Kate Rochlin, COO, In8Bio, Lawrence Lamb, EVP, CSO and Co- Founder, IN8Bio, Daniel Olive, Group Leader, INSERM, Bruno Silva-Santos, Group Leader, Instituto de Medicina Molecular, Paul Parren, Head of R and D, Lava Therapeutics, Rob Roovers, Senior Director Preclinical Development, Lava Therapeutics, Caroline Hull, Team Lead, Leucid Bio, Daniel Abate-Daga, Associate Member, Moffitt Cancer Center, Richard Lopez, Founder and CEO, PhosphoGam, Jianqiang Li, Founder and CSO, SenlangBio, Serhat Gumrukcu, Executive Director and Director of Translational Research, Seraph Research Institute, Anne Lai, Principal Scientist, Shattuck Labs, Alice Cheung, Senior Research Scientist, Singapore General Hospital, Alice Bertaina, Associate Professor of Pediatrics, Stanford, Angela Scott, Co-Founder and COO, TC Biopharm, Emilio Cosimo, Product Development Manager, TC Biopharm, Michael Leek, Co-Founder and Executive Chairman, TC Biopharm, Adrian Hayday, Senior Group Leader, The Francis Crick Institute, John Anderson, Professor of Experimental Pediatric Oncology and Honorary Consultant Oncologist, UCL Great Ormond Street Institute of Child Health

Schedule:

08:30 - 17:45

Registration Fee Details:

Drug Developer Pricing - Conference + Pre-Conference Day (Conference + 3 workshops): USD 3896.00,
Drug Developer Pricing - Conference Only: USD 2999.00,
Academic Pricing - Conference + Pre-Conference Day (Conference + 3 workshops): USD 2796.00,
Academic Pricing - Conference Only: USD 2199.00,
Service Provider Pricing - Conference + Pre-Conference Day (Conference + 3 workshops): USD 4796.00,
Service Provider Pricing - Conference Only: USD 3599.00

Other items that tuition includes:

Travel and hotel arrangements:

 
 
Contact Person:Jessica Durston
Contact Emailinfo@hansonwade.com
Organizer State/Province: (Outside US)
Organizer CountryData not provided
Organizer Phone+1 617 455 4188
Structural makeupData not provided
Host Sponsor; Other SponsorsHanson Wade
Event Site/VenueThe Colonnade Hotel
Event sold out?No
Multiple locations or dates?No
Statistics available for most recent event held in:NA
Average number in event attendance of:
Range:
Number in attendance of:
Range:
Target BoundariesInternational
Is Registration contact information the same as Organizer Contact above?Yes
Web Page https://go.evvnt.com/1089722-2?pid=5188
Can one register for your CE on your web site?NA
Can registration be made by snail (regular) mail?Yes
Online housing reservations: 
 
Do you have additional written or AV materials for sale?No
If so, are they available for non-attendees as well as those attending?NA
Is full tuition necessary to ensure registration?No
Will there be shuttle service available?NA
Additional notes:

Brochure: https://go.evvnt.com/1089722-0?pid=5188

Sign In/Sign Out
About Us
FAQ
Contact Us